safety | CMAC

safety

Pharmacotherapy of Vulvovaginal Candidiasis According to Pharmacoepidemiology Data and Evidence-Based Medicine

Approximately 75% of women experience at least one episode of acute vulvovaginal candidiasis during their life. In the 1980-90s, almost two-fold increase in fungal vaginitis was observed with increase in number of cases caused by non-albicans strains …

Use of Carbapenems in Clinical Practice: When, Which and How Long?

Carpabenems (imipenem, meropenem, ertapenem) are currently one of the antibiotic classes that exhibit the broadest spectrum of activity and characterized by the low resistance rates of clinically significant pathogens. This article is an attempt to …

Potential for the Use of Probiotics in Clinical Medicine

Currently, prophylactic and therapeutic use of probiotics is a common practice worldwide, although their effectiveness remains controversial. This review presents data on main probiotic microorganisms. This paper summarizes available evidence-based …